PDFファイル
Contents
1. B F 4 4 D 1 2 8 C 24 24 20 C 60 2 8 C 15 25 C 22. 3 4 10 5 2 D 1 EIA TEMA D D
3. D 90 6 16 0 rg mL 1 5 AIA 2000 PTgm Fate p 0 1 2 3 4 5 6 7 8 9 1011 121814 151817 18 19 Cone 1 1 BE TOSOH II D D 2 3 131 D
4. 5 2 8C 24 24 20 C 60 6 2 Mammen EF Disseminated intravascular coagulation DIC Clin Lab Sci 13 239 245 2000 3 Yu M Nardella A and Pechet L Screening tests of disseminated intraVascular coagulation guidelines for rapid and specific laboratory diagnosis Crit Care Med 28 1777 1780 2000 4 DIC 41 232 236 2007 5 Anderson DR and Wells PS D dimer for the diagnosis of venous thromboembolism Curr Opin Hematol 7 296 301 2000 6 Perrier A Desmarais S Goehring C de Moerloose P Morabia A Unger PF et al D dimer testing for suspected pulmonary embolism in outpatients Am J Respir Crit Care Med 156 492 496 1997 7
5. D 57 805 810 2008 252 1123 2743 1 O120 17 1200 TEL 0467 76 5384 FAX 0467 79 2550 Toson 3 8 2 TEL 03 5427 5181 FAX 03 5427 5220 TosoH 2
6. 95 0 5 g mL 2 1 2 SI D g mL SI g L A gD ug D mL x 1 000 D XDP cross linked fibrin degradation products D DIC disseminated intravascular coagu
7. 3 1 2 8C 2 12 16 g mL 2 100 20 2 D EE 5 TOSOH II D 0025232 E TOSOH IL D 100 D D D 5 3 1 D
8. 3 B TOSOH II D 4 440 mg dL 17 mg dL 18 mg dL 1 600 mg dL 5 g dL 20 mg dL 3Na 20 mg mL 5 2 8 C 15 25 C 1 1 E TOSOH TII D 15 25 C 96 1 15 25 C 8 2 8 C 16
9. 1 BE TOSOH II D D D 2 B TOSOH TII SUB II 1 E TOSOH HI 4 2 E TOSOH II 3 E TOSOH II D E TOSOH II D 1 E TOSOH II D 2 E TOSOH II D 3 E TOSOH II D 4 E TOSOH II D 5 E TOSOH II D 6 4 B TOSOH II D 5 B TOSOH I 6 E TOSOH I D 1 1 D 1 EIA IEMA 2
10. 3 0 02 1 0 g mL 1 1 6 0 kg gmL 6 1 602 OE TOSOH II D 1 0 mL x2 16 gmL 5 2 6 15 1 0 mL x2 A 4 0 02 16 0 g mL 5 0025532 TOSOH TT D 4 0 mL x4 0 02 g mL 1 6 1 FU y 2 x SD 5 E TOSOH I 400 g mL 0015968 BE TOSOH II 100 mL x2 E TOSOH II 100 mL x2 0015955 E TOSOH II 100 mL x4 5 x 1 y A x 0015956 E TOSOH I O00
11. 10 11 12 2 1 HIV HBV HCV 2 1 3 1 2 121 C 20
12. y 1 1x 0 26 r 0 96 1 Carey MJ and Rodgers GM Disseminated intravascular coagulation Clinical n 105 and laboratory aspects Am J Hemat 59 65 73 1998 2 y B CLEIA x y 0 91 x 0 21 r 0 93 n 62 1 1 2 3 4 90 90
13. 1 2 3 1 E TOSOH II D 2 140 L 10 x L 37 C 10 3 B F 4 363 nm 447 nm 5
14. 12 2 8 C 30 2 E TOSOH II 1 BE TOSOHI II 1 100 mL 15 25 C 3 2 8 C 30 3 E TOSOH II D 1 E TOSOH II D 2 6 1 0 mL 2 8 1 E TOSOH II D 4 E TOSOH
15. 8 D 9 HAMA Human Anti Mouse Antibody
16. II D 15 25 C 72 15 25 C 1 8 2 8C 9 2 8C 90 5 E TOSOH TII 1 2 5 L 15 25 C 30 6 E TOSOH II 1 5 L 15 25 C 30 2
17. 100A471001 033A 2013 3 1 225ABAMX00022000 E TOSOH II D EIA D 1 2 3 4 HBs HIV HCV 5
18. lation 7 4 5 1 1 E TOSOH II D 1 FU 0 2 nmol L s 2 BE TOSOH II D 1 E TOSOH II D 2 FU FU 1 1 2 nmo L s gu gmL 1 FU FU A B C A 2 FU B 1 FU C 2 D nmol L s nmol L s gmL 2 D 3 0 02 1 0 gmL 1 1 6 0 gmL 6 1 7 E TOSOH II D E TOSOH II D E TOSOH II SUB II E TOSOH II E TOSOH II
Download Pdf Manuals
Related Search